Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myogenic factor 5 (MYF5) is a basic helix-loop-helix transcription factor and an early-expressed member of the myogenic regulatory factor family, which also includes MyoD, myogenin, and MRF4[1][3]. MYF5 plays a master regulatory role in the commitment of precursor cells to the skeletal muscle lineage during embryogenesis and is a key determinant of muscle cell fate[1][2][3]. It activates transcription of muscle-specific genes and can induce non-muscle cells to adopt a muscle phenotype[1][5]. MYF5 expression is tightly regulated by various enhancer elements and is essential for proper early muscle development, with additional indirect roles in rib formation and brown adipose tissue lineage specification[1]. In the adult, MYF5 is expressed in satellite cells and is involved in post-injury muscle regeneration[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myogenic factor 5 (MYF5).